Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However, frequent irregular...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Bioavailability Study Design: Healthy Subjects Versus Patients01:15

Bioavailability Study Design: Healthy Subjects Versus Patients

Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
Relative Risk01:12

Relative Risk

Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Roles and impact of pharmacy technicians on hospital wards: a systematic review.

International journal of nursing studies advances·2026
Same author

Quality and methodological heterogeneity of COVID-19 vaccine safety studies focusing on the myocarditis safety signal: A systematic review, meta-analysis and meta-regression.

Vaccine·2026
Same author

Pharmaceutical technical assistants on hospital wards: Qualitative interdisciplinary perspectives.

Exploratory research in clinical and social pharmacy·2026
Same author

Conducting Medication Reviews: A Comparative Study Between ChatGPT-4 and Healthcare Professionals.

Journal of the American Geriatrics Society·2026
Same author

The Effect of Use of Tricyclic Antidepressants or Serotonin-Norepinephrine Reuptake Inhibitors Versus Selective Serotonin Reuptake Inhibitors on the Risk of Urinary Tract Infection Among People With Multiple Sclerosis: A Nested Case-Control Study.

Pharmacoepidemiology and drug safety·2025
Same author

Patient preferences and attitudes regarding the environmental impact of medicines: A discrete choice experiment.

British journal of clinical pharmacology·2025

Related Experiment Video

Updated: Jul 2, 2026

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.6K

Early Identification of Cardiovascular Adverse Events Associated With Rofecoxib Using Real-World Data From the UK: A

Donya Moslemzadeh1, Patrick C Souverein1, Svetlana V Belitser1

  • 1Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, the Netherlands.

Pharmacoepidemiology and Drug Safety
|March 9, 2026
PubMed
Summary
This summary is machine-generated.

Real-world data (RWD) analysis detected rofecoxib

Keywords:
case‐crossover designmajor adverse cardiovascular eventnested case–control designreal‐world datarofecoxib

More Related Videos

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.1K
Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
08:45

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients

Published on: April 18, 2025

1.5K

Related Experiment Videos

Last Updated: Jul 2, 2026

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy
11:38

Voluntary Breath-hold Technique for Reducing Heart Dose in Left Breast Radiotherapy

Published on: July 3, 2014

47.6K
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
07:22

Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes

Published on: March 7, 2025

1.1K
Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients
08:45

Echocardiographic Assessment Using Subxiphoid-Only Examination for Hypotensive Patients

Published on: April 18, 2025

1.5K

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Epidemiology
  • Real-World Data Analysis

Background:

  • Traditional pharmacovigilance systems struggle to identify common adverse drug reactions.
  • Rofecoxib was associated with significant cardiovascular risks.
  • Early detection of adverse drug events is crucial for public health.

Purpose of the Study:

  • To evaluate if real-world data (RWD) could have enabled earlier detection of rofecoxib's cardiovascular adverse effects.
  • To compare the effectiveness of nested case-control (NCC) and case-crossover (CCO) designs in RWD analysis.
  • To determine the minimum time required for RWD to signal drug-induced cardiovascular risks.

Main Methods:

  • Utilized UK CPRD GOLD data (1999-2004) for adult rofecoxib users.
  • Employed nested case-control (NCC) and case-crossover (CCO) study designs.
  • Analyzed drug exposure at different time points post-market entry (1-5 years) to identify the earliest detection window.

Main Results:

  • The case-crossover design identified an 83% increased risk of major adverse cardiovascular events (MACE) with rofecoxib use (aIR 1.83).
  • A significant signal for MACE was detected after 2 years using the CCO design (aIR 3.94).
  • The NCC design detected a significant signal after 3 years (aIR 1.46), indicating a 18% increased risk.

Conclusions:

  • Real-world data analysis, particularly using the CCO design, could have detected rofecoxib's cardiovascular risks within 2 years of market entry in the UK.
  • This demonstrates the potential of RWD to enhance traditional pharmacovigilance by providing earlier safety signals.
  • Integrating RWD analysis into routine drug safety monitoring is recommended for proactive risk management.